Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic rece…
Biotechnology
US, Boston [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 2 | $5,000,000 | LD-2 : 07/22/24 |
| 2024 | 1 | $5,000,000 | LD-2 : 04/22/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/22/24 |